HomeCompareWBA vs SCI

WBA vs SCI: Dividend Comparison 2026

WBA yields 2.09% · SCI yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCI wins by $7.1K in total portfolio value
10 years
WBA
WBA
● Live price
2.09%
Share price
$11.98
Annual div
$0.25
5Y div CAGR
-18.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$30.14
Full WBA calculator →
SCI
SCI
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full SCI calculator →

Portfolio growth — WBA vs SCI

📍 SCI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWBASCI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WBA + SCI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WBA pays
SCI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WBA
Annual income on $10K today (after 15% tax)
$177.38/yr
After 10yr DRIP, annual income (after tax)
$25.62/yr
SCI
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, SCI beats the other by $738.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WBA + SCI for your $10,000?

WBA: 50%SCI: 50%
100% SCI50/50100% WBA
Portfolio after 10yr
$24.5K
Annual income
$464.67/yr
Blended yield
1.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SCI right now

WBA
Analyst Ratings
5
Buy
17
Hold
9
Sell
Consensus: Hold
Price Target
$23.57
+96.7% upside vs current
Range: $9.00 — $57.00
Altman Z
2.3
Piotroski
4/9
SCI
Analyst Ratings
8
Buy
1
Hold
Consensus: Buy
Price Target
$96.33
+92.7% upside vs current
Range: $94.00 — $100.00
Altman Z
0.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WBA buys
0
SCI buys
0
No recent congressional trades found for WBA or SCI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWBASCI
Forward yield2.09%4.00%
Annual dividend / share$0.25$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR-18.1%5%
Portfolio after 10y$21.0K$28.0K
Annual income after 10y$30.14$899.19
Total dividends collected$841.00$6.4K
Payment frequencyquarterlyquarterly
SectorConsumer StaplesIndustrials
Analyst consensusHoldBuy
Analyst price target$23.57$96.33

Year-by-year: WBA vs SCI ($10,000, DRIP)

YearWBA PortfolioWBA Income/yrSCI PortfolioSCI Income/yrGap
1← crossover$10,871$170.91$11,120$420.00$249.00SCI
2$11,774$142.21$12,357$458.31$583.00SCI
3$12,716$117.89$13,721$499.76$1.0KSCI
4$13,704$97.46$15,227$544.58$1.5KSCI
5$14,743$80.39$16,885$593.02$2.1KSCI
6$15,842$66.20$18,713$645.34$2.9KSCI
7$17,005$54.45$20,724$701.81$3.7KSCI
8$18,240$44.73$22,938$762.73$4.7KSCI
9$19,554$36.73$25,372$828.41$5.8KSCI
10$20,953$30.14$28,047$899.19$7.1KSCI

WBA vs SCI: Complete Analysis 2026

WBAConsumer Staples

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Full WBA Calculator →

SCIIndustrials

SCI is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SCI shares.

Full SCI Calculator →
📬

Get this WBA vs SCI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WBA vs SCHDWBA vs JEPIWBA vs OWBA vs KOWBA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.